Target and Pathway |
Top |
Target(s) |
Apoptosis regulator Bcl-2 (BCL-2) |
Target Info
|
Modulator |
[2] |
Erbb2 tyrosine kinase receptor (HER2) |
Target Info
|
Inhibitor |
[2] |
Human Deoxyribonucleic acid (hDNA) |
Target Info
|
Binder |
[1] |
KEGG Pathway
|
NF-kappa B signaling pathway
|
HIF-1 signaling pathway
|
Sphingolipid signaling pathway
|
Protein processing in endoplasmic reticulum
|
PI3K-Akt signaling pathway
|
Apoptosis
|
Adrenergic signaling in cardiomyocytes
|
Focal adhesion
|
Neurotrophin signaling pathway
|
Cholinergic synapse
|
Amyotrophic lateral sclerosis (ALS)
|
Toxoplasmosis
|
Tuberculosis
|
Hepatitis B
|
Epstein-Barr virus infection
|
Pathways in cancer
|
MicroRNAs in cancer
|
Colorectal cancer
|
Prostate cancer
|
Small cell lung cancer
|
ErbB signaling pathway
|
Calcium signaling pathway
|
Adherens junction
|
Proteoglycans in cancer
|
Pancreatic cancer
|
Endometrial cancer
|
Bladder cancer
|
Non-small cell lung cancer
|
Central carbon metabolism in cancer
|
NetPath Pathway
|
IL5 Signaling Pathway
|
TCR Signaling Pathway
|
IL2 Signaling Pathway
|
IL3 Signaling Pathway
|
Leptin Signaling Pathway
|
RANKL Signaling Pathway
|
TSLP Signaling Pathway
|
Panther Pathway
|
Apoptosis signaling pathway
|
Oxidative stress response
|
CCKR signaling map ST
|
Cadherin signaling pathway
|
EGF receptor signaling pathway
|
Pathwhiz Pathway
|
Phosphatidylinositol Phosphate Metabolism
|
Pathway Interaction Database
|
Role of Calcineurin-dependent NFAT signaling in lymphocytes
|
IL2-mediated signaling events
|
IL2 signaling events mediated by PI3K
|
Ceramide signaling pathway
|
Direct p53 effectors
|
RXR and RAR heterodimerization with other nuclear receptor
|
ATF-2 transcription factor network
|
C-MYB transcription factor network
|
HIV-1 Nef: Negative effector of Fas and TNF-alpha
|
Caspase Cascade in Apoptosis
|
Signaling events mediated by Stem cell factor receptor (c-Kit)
|
EPO signaling pathway
|
IL2 signaling events mediated by STAT5
|
Validated targets of C-MYC transcriptional repression
|
ErbB4 signaling events
|
ErbB2/ErbB3 signaling events
|
ErbB receptor signaling network
|
a6b1 and a6b4 Integrin signaling
|
Reactome
|
Activation of BAD and translocation to mitochondria
|
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
|
The NLRP1 inflammasome
|
SHC1 events in ERBB2 signaling
|
PLCG1 events in ERBB2 signaling
|
PIP3 activates AKT signaling
|
GRB2 events in ERBB2 signaling
|
PI3K events in ERBB2 signaling
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
Sema4D induced cell migration and growth-cone collapse
|
RAF/MAP kinase cascade
|
WikiPathways
|
DNA Damage Response (only ATM dependent)
|
Senescence and Autophagy in Cancer
|
IL-2 Signaling Pathway
|
FAS pathway and Stress induction of HSP regulation
|
Focal Adhesion
|
Kit receptor signaling pathway
|
IL-3 Signaling Pathway
|
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
|
Apoptosis
|
Nanoparticle triggered autophagic cell death
|
Amyotrophic lateral sclerosis (ALS)
|
Integrated Pancreatic Cancer Pathway
|
Corticotropin-releasing hormone
|
Interleukin-11 Signaling Pathway
|
Prostate Cancer
|
miR-targeted genes in muscle cell - TarBase
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in leukocytes - TarBase
|
Integrated Breast Cancer Pathway
|
Integrated Cancer pathway
|
Intrinsic Pathway for Apoptosis
|
Apoptosis Modulation and Signaling
|
TP53 Network
|
Influenza A virus infection
|
IL-5 Signaling Pathway
|
ErbB Signaling Pathway
|
EGF/EGFR Signaling Pathway
|
Extracellular vesicle-mediated signaling in recipient cells
|
Bladder Cancer
|
Signaling by ERBB2
|
Signaling Pathways in Glioblastoma
|
Leptin signaling pathway
|
Semaphorin interactions
|